Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Offer for Trinity Exploration & Production Plc Waiver of Condition and Offer Declared Final
-
BGL Welcomes Seth Rosenfield as a Managing Director within Services
-
Canaccord Genuity Reiterates Buy Rating on SI-BONE Inc. (SIBN)
-
Houlihan Lokey (HLI) Appoints Geoff Rhizor as Managing Director
-
Houlihan Lokey Expands Global Technology Group With Senior Software Hire
-
Form 8.3 - [IQGEO GROUP PLC - 19 08 2024] - (CGAML)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 19 08 2024] - (CGWL)
-
Zimmer Biomet (ZBH) PT Lowered to $120 at Canaccord Genuity
-
Doximity Inc (DOCS) PT Raised to $40 at Canaccord Genuity
-
Fluent Inc. (FLNT) PT Lowered to $4 at Canaccord Genuity
-
Falfurrias Management Partners Announces Investment in Jumo Health, An Innovative Clinical Trial Solutions Platform Driving Better Health Outcomes
-
Tectonic Metals Set to Commence Drilling After Successfully Closing Oversubscribed $3 Million Private Placement; Extends Offering by $1 Million
-
Canaccord Genuity Reiterates Buy Rating on Intuitive Machines Inc. (LUNR)
-
Ninepoint Partners Announces Ninepoint 2024 Short Duration Flow-Through Limited Partnership II
-
Benton Closes Private Placement of Flow-Through Units
-
Estee Lauder (EL) PT Lowered to $100 at Canaccord Genuity
-
Quipt Home Medical Corp. (QIPT) PT Lowered to $6 at Canaccord Genuity
-
ESS Inc. (GWH) PT Lowered to $1 at Canaccord Genuity
-
Vertical Aerospace Ltd. (EVTL) PT Lowered to $1.50 at Canaccord Genuity
-
Interim Management Statement Q3 2024
-
Canaccord Genuity Reiterates Buy Rating on Corcept Therapeutics (CORT)
-
Canaccord Genuity Reiterates Buy Rating on JFrog (FROG)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 14 08 2024] - (CGWL)
-
Canaccord Genuity Upgrades Charter Hall Social Infrastructure REIT (CQE:AU) (FKKEF) to Buy
-
Valeura Energy Inc Announces Nong Yao C First Oil
-
Thor Explorations Ltd. Announces Appointment of Auditor
-
QuoteMedia Announces Financial Results for Q2 2024
-
Form 8.3 - [IQGEO GROUP PLC - 13 08 2024] - (CGAML)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 13 08 2024] - (CGWL)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 12 08 2024] - (CGWL)
-
Taysha Gene Therapies (TSHA) PT Lowered to $6 at Canaccord Genuity
-
Glass House Brands Reports Record Setting Second Quarter 2024 Financial Results
-
Canaccord Genuity Comments on Globus Medical (GMED) Warning Letter: 'we view this issue as growing pains'
-
Trulieve Announces August 2024 Event Participation
-
TTEC Holdings Inc. (TTEC) PT Lowered to $4.50 at Canaccord Genuity
-
TELA Bio, Inc. (TELA) PT Lowered to $12 at Canaccord Genuity
-
monday.com Ltd. (MNDY) PT Raised to $295 at Canaccord Genuity
-
Neuronetics (STIM) PT Lowered to $3 at Canaccord Genuity
-
RETRANSMISSION: HIVE Announces Quarterly Revenue of $32.2 Million, Adjusted EBITDA of $14.9 Million with an Increase in Bitcoin Holdings to 2,496 Bitcoin, 449 Bitcoin Mined and HPC Expansion
-
HIVE Announces Quarterly Revenue of $32.2 Million, Adjusted EBITDA of $14.9 Million with an Increase in Bitcoin Holdings to 2,496 Bitcoin, 449 Bitcoin Mined and HPC Expansion
-
i-80 Gold Establishes At-the-Market Equity Program
-
Arq Reports Second Quarter 2024 Results
-
Jamf Announces Upcoming Conference Participation
-
Enovis to Participate in Upcoming Investor Conferences
-
Cibus to Participate in Upcoming August Investor Events
-
Evercommerce to Present at August 2024 Investor Conferences
-
Above Food to Participate in the 44th Annual Canaccord Genuity Growth Conference
-
Open Lending to Attend the Canaccord Genuity 44th Annual Growth Conference
-
Ameresco to Participate at Upcoming Conference
-
Neuronetics (STIM) and Greenbrook TMS Announce Definitive Agreement to Merge
